Skip to main content

Never mind the GRANOLAS, what about the CHEERIOS?

With Europe’s answer to the Magnificent Seven looking fully valued, chief investment officer Paras Anand offers an alternative acronym for breakfast-cereal lovers that he thinks investors might benefit from investigating.

Like the Magnificent Seven in the US, the GRANOLAS have come to dominate the European stock market. The recent correction across the Atlantic should be a warning of what can happen here.

This group of 11 companies now represents more than 20%1 of the European equity market – similar, astonishingly, to the combined weight of energy, basic resources, banks, financial services and automobiles.

The list comprises GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L’Oreal, LVMH, AstraZeneca, Sanofi and SAP – global leaders in pharmaceuticals, beauty and food.

Just like the Magnificent Seven (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla), the GRANOLAS have been responsible for a large proportion of market returns. And their solid stock price performance has been justified by strong earnings growth.

But they might not be as healthy for investor returns from here on as the acronym suggests. These companies are now looking richly valued, with an average P/E ratio of 25x2, and are perhaps a little too over consumed by investors.

The Artemis SmartGARP® process screens and filters thousands of companies to identify a smaller subset for closer assessment that have the most attractive fundamentals at the best price. Most of these have been overlooked by investors. The process combines top-down and bottom-up factors including growth, value, momentum and sentiment.

As a result of that analysis, the Artemis SmartGARP European Equity Fund owns just three of the GRANOLAS – an 18%5 underweight position versus the index. But it owns an alternative group that we think lovers of breakfast cereal acronyms might benefit from investigating: the CHEERIOS.

Stock Sector Country Portfolio weight (%) SmartGARP Score P/E ratio
Coface Insurance France 1.2 95 8.2
H. Lundbeck Healthcare Denamrk 1.5 100 7.4
Evonik    Chemicals Germany 1.2 74 12.9
Eramet 
Basic resources
France 1.1  91  6.8 
Repsol
Oil & Gas
Spain 2.7  90  4.2 
Indra Sistemas
Technology
Spain 1.6  98 12.1 
OTP Bank
Banks
Hungary 2.0  95 5.0 
SAF-Holland 
Automobiles & Parts 
Germany  0.7 96  7.2 
Source: Company results/Bloomberg as of 27/07/2024

Coface is one of the top three trade credit insurers in the world, serving 100,000 companies. This is a highly concentrated market with strong barriers to entry. Despite limited exposure to its domestic market, the recent sell-off in French stocks has left the valuation of the shares looking particularly attractive, trading on a P/E of 8.2x3 and producing a dividend yield of 10.2%4.

H. Lundbeck develops and commercialises specialised products for the treatment of brain diseases, giving it a strong competitive advantage within neurological and psychiatric disorders. Supported by patents, it has a global presence with the potential to increase its presence in emerging markets, where there is growing demand for healthcare solutions. The company is one of the highest scoring companies in the SmartGARP universe, thanks to strong momentum and quality scores.

Evonik is a diversified German chemical company with a relatively high share of specialties in its portfolio. It operates in four divisions and is a leading producer of the feed ingredient methionine. With industrial businesses having shown an ability to bounce back meaningfully in past earnings recoveries, Evonik has one of the most resilient earnings profiles, and we have started to see positive analyst sentiment towards the company, a factor that holds particular importance in the SmartGARP process.

Eramet is a French metals and mining company. The group is a major low-cost producer and leader in alloy metals, particularly manganese and nickel, as well as mineral sands. Manganese is geared to global steel volumes, under pressure since Covid. The ongoing weakness in Chinese property and near-term supply additions in a few of Eramet's products have led to the company’s cheap valuation, but it scores in the top percentile when we look at the revisions factor (analyst sentiment).

Repsol is a Spanish integrated oil & gas company with E&P (exploration & production) activities across the globe. The group has a sizeable and high-quality downstream portfolio and is a leading player in setting bold GHG (greenhouse gas) emission reduction targets, with potential to develop low-carbon investments. Sentiment towards the stock is negative, resulting in a compelling valuation, despite a strong macroeconomic tailwind.

Indra Sistemas is a Spanish technology company that provides IT services to industries such as defence, air traffic management and transport. It has market-leading positions in a number of segments with strong order pipelines. The business scores particularly well on analyst sentiment and share price momentum, whilst also trading at a discount to the market and its sector.

OTP Bank is a leading regional banking franchise in Hungary and the CEE (Central and Eastern Europe) region. The bank was hit by the negative impacts of the Russian invasion of Ukraine, but moderating impairment charges and successful recent M&A have driven a strong recovery in earnings. OTP has been deploying excess capital to enter new markets and improve its position in existing ones. The bank’s strong franchise in the region, solid capital generation and good long-term growth prospects drive attractive SmartGARP momentum, as well as value and revisions scores.

SAF-Holland is a leading global supplier of components and systems equipment for trailers and trucks. This is an attractive market segment, particularly the high-margin after-market area. SAF-Holland has opportunities to benefit from market share gains and strong growth opportunities in emerging markets. The stock is seeing positive earnings revisions trends, yet trades on a compelling valuation, resulting in an attractive SmartGARP score.

Sweet investment returns

Cheerios is a whole-grain cereal, low in fat and calories, but it also includes sugar; there is always a downside. Similarly, no investment is without risk. But if the returns from these eight stocks are as sweet as we hope they will be in the coming years, few shareholders will complain.

1,2,3,4 Source: Bloomberg, 30 June 2024
Source: Artemis, 30 June 2024

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.